Sex-hormone-binding globulin early in pregnancy for the prediction of severe gestational diabetes mellitus and related complications

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 11, 2012, Pages 1286-1293

  Caglar, Gamze S ^a   Ozdemir, Elif D U ^a   Cengiz, Sevim D ^a   Demirtas, Selda ^a  

^a UFUK UNIVERSITY   (Turkey)

Author keywords

Gestational diabetes mellitus; Insulin therapy; Perinatal outcome; Prediction of gestational iabetes; Sex hormone binding globulin

Indexed keywords

INSULIN; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DIET THERAPY; FEMALE; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; DIABETES, GESTATIONAL; FEMALE; HUMANS; LOGISTIC MODELS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX HORMONE-BINDING GLOBULIN;

EID: 84869169065     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2012.01870.x     Document Type: Article

References (29)

1. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002. (Pubitemid 351656454)
2. Ferrara A,Weiss NS, HeddersonMMet al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycemia and hyperbilirubinaemia. Diabetologia 2007; 50: 298-306.
3. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477-2486. (Pubitemid 41007863)
4. Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: The consequences of not treating. Am J Obstet Gynecol 2005; 192: 989-997. (Pubitemid 40487770)
5. American College of Obstetricians and Gynecologists Committee on Practice Bulletins: Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetriciangynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. 2001; 98: 525-538.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29: 43-48.
7. Thadhani R, Wolf M, Hsu-Blatman K, Sandler L, Nathan D, Ecker JL. First trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. Am J Obstet Gynecol 2003; 189: 171-176. (Pubitemid 36886544)
8. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003; 26: 819-824. (Pubitemid 36929349)
9. Smirnakis KV, Martinez A, Blatman KH, Wolf M, Ecker JL, Thadhani R. Early pregnancy insulin resistance and subsequent gestational diabetes mellitus. Diabetes Care 2005; 28: 1207-1208. (Pubitemid 40616637)
10. Smirnakis KV, Plati A, Wolf M, Thadhani R, Ecker JL. Predicting gestational diabetes: Choosing the optimal early serum marker. Am J Obstet Gynecol 2007; 196: 410.e1-410.e7.
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 24: S5-S20.
12. Pugeat M, Nader N, Hogeveen K, Raverot G, Dechaud H, Grenot C. Sex hormone-binding globulin gene expression in the liver: Drugs and the metabolic syndrome. Mol Cell Endocrinol 2010; 316: 53-59.
13. PugeatM, Crave JC, Touniaire J, Forest MG. Clinical utility of sex hormone-binding globulin measurement. Horm Res 1996; 45: 148-155. (Pubitemid 26079699)
14. Ding EL, Song Y, Manson JE et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009; 361: 1152-1163.
15. Ding EL, Song Y, Malik VD, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2006; 295: 1288-1299.
16. Kerlan V, Nahoul K, Le Martelot MT, Bercovici JP. Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy. Clin Endocrinol (Oxf) 1994; 40: 263-267. (Pubitemid 24193158)
17. O'Leary P, Boyne P, Flett P, Beilby J, James I. Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin Chem 1991; 37: 667-672. (Pubitemid 21892706)
18. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991; 165: 1667-1672.
19. Stanley K, Fraser R, Bruce C. Physiological changes in insulin resistance in human pregnancy: Longitudinal study with the hyperinsulinaemic euglycaemic clamp technique. Br J Obstet Gynaecol 1998; 105: 756-759. (Pubitemid 28350001)
20. Stefan N, Kantartzis K, Haring U. Causes and metabolic consequences of fatty liver. Endocr Rev 2008; 29: 939-960.
21. Yu CK, Papageorghiou AT, Bindra R, Spencer K, Nicolaides KH. Second-trimester sex hormone-binding globulin and subsequent development of pre-eclampsia. J Matern Fetal Neonatal Med 2004; 16: 158-162. (Pubitemid 40006902)
22. Bartha JL, Comino-Delgado R, Romero-Carmona R, Gomez-Jaen MC. Sex hormone-binding globulin in gestational diabetes. Acta Obstet Gynecol Scand 2000; 79: 839-845.
23. Kopp HP, Festa A, Krugluger W, Schernthaner G. Low levels of sex hormone-binding globulin predict insulin requirement in patients with gestational diabetes mellitus. Exp Clin Endocrinol Diabetes 2001; 109: 365-369. (Pubitemid 32977417)
24. Mak W, Dokras A. Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis. Semin Thromb Hemost 2009; 35: 613-620.
25. Dahan MH, Goldstein J. Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2006; 86: 934-941. (Pubitemid 44485027)
26. Veltman-Verhulst SM, van Haeften TW, Eijkemans MJC, de Valk HW, Fauser BC, Goverde AJ. Sex hormone binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome. Hum Reprod 2010; 25: 3123-3128.
27. Athukorala C, Crowther CA,Willson K, Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) trial group. Women with gestational diabetes mellitus in the ACHOIS trial: Risk factors for shoulder dystocia. Aust N Z J Obstet Gynaecol 2007; 47: 37-41. (Pubitemid 46152468)
28. Joffe GM, Esterlitz JR, Levine RJ et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for preeclampsia prevention (CPEP) study group. Am J Obstet Gynecol 1998; 179: 1032-1037. (Pubitemid 28489303)
29. Spencer K, Yu CK, Rembouskos G, Bindra R, Nicolaides KH. First trimester sex hormone-binding globulin and subsequent development of preeclampsia or other adverse pregnancy outcomes. Hypertens Pregnancy 2005; 24: 303-311. (Pubitemid 41579640)